These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 8485625

  • 1. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
    Bristow LJ, Hutson PH, Thorn L, Tricklebank MD.
    Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
    [Abstract] [Full Text] [Related]

  • 2. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
    Hutson PH, Barton CL, Jay M, Blurton P, Burkamp F, Clarkson R, Bristow LJ.
    Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
    [Abstract] [Full Text] [Related]

  • 3. Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain.
    Kuroki T, Tatebayashi Y, Ide K, Yonezawa Y, Tsutsumi T, Matsumoto T, Hirano M, Uchimura H.
    Neuropeptides; 1992 Mar; 21(3):167-73. PubMed ID: 1385857
    [Abstract] [Full Text] [Related]

  • 4. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD, Bristow LJ, Hutson PH, Leeson PD, Rowley M, Saywell K, Singh L, Tattersall FD, Thorn L, Williams BJ.
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [Abstract] [Full Text] [Related]

  • 5. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
    Hutson PH, Bristow LJ, Thorn L, Tricklebank MD.
    Br J Pharmacol; 1991 Aug; 103(4):2037-44. PubMed ID: 1655150
    [Abstract] [Full Text] [Related]

  • 6. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W, Wlaź P, Rundfeldt C, Baran H, Hönack D.
    Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine.
    French ED, Ferkany J, Abreu M, Levenson S.
    Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
    Lapin IP, Rogawski MA.
    Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M, Cho AK, Nabeshima T.
    Eur J Pharmacol; 1989 Aug 03; 166(3):359-66. PubMed ID: 2553433
    [Abstract] [Full Text] [Related]

  • 14. Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.
    Schmidt CJ, Fadayel GM.
    J Pharmacol Exp Ther; 1996 Jun 03; 277(3):1541-9. PubMed ID: 8667221
    [Abstract] [Full Text] [Related]

  • 15. Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.
    Abekawa T, Ito K, Nakagawa S, Koyama T.
    Psychopharmacology (Berl); 2007 Jun 03; 192(3):303-16. PubMed ID: 17340116
    [Abstract] [Full Text] [Related]

  • 16. Selective interaction of nitric oxide synthase inhibition with phencyclidine: behavioural and NMDA receptor binding studies in the rat.
    Klamer D, Zhang J, Engel JA, Svensson L.
    Behav Brain Res; 2005 Apr 15; 159(1):95-103. PubMed ID: 15795002
    [Abstract] [Full Text] [Related]

  • 17. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.
    Jentsch JD, Elsworth JD, Redmond DE, Roth RH.
    J Neurosci; 1997 Mar 01; 17(5):1769-75. PubMed ID: 9030635
    [Abstract] [Full Text] [Related]

  • 18. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle.
    Keith VA, Mansbach RS, Geyer MA.
    Biol Psychiatry; 1991 Sep 15; 30(6):557-66. PubMed ID: 1834231
    [Abstract] [Full Text] [Related]

  • 19. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM, Steele TD, Sharpe LG.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):46-52. PubMed ID: 8996180
    [Abstract] [Full Text] [Related]

  • 20. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat.
    Goldstein LE, Rasmusson AM, Bunney BS, Roth RH.
    J Neurosci; 1994 Aug 15; 14(8):4937-50. PubMed ID: 8046462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.